The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


Coupang Reports Q4 Loss After Data Breach, Revenue Misses Estimates
Gold Prices Rally in February as Geopolitical Risks and Economic Uncertainty Boost Safe-Haven Demand
IMF Urges U.S. to Cut Fiscal Deficit to Reduce Trade and Current Account Gaps
Australian Dollar Rallies on Hawkish RBA Outlook; Yen Slips as BOJ Faces Political Pressure
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
U.S. Stocks Close Lower as Hot PPI Data, Nvidia Slide Weigh on Wall Street
Gold Prices Steady in Asia, Set for Strong February Gains on Safe-Haven Demand
Snowflake Forecasts Strong Fiscal 2027 Revenue Growth as Enterprise AI Demand Surges
Panama Investigates CK Hutchison’s Port Unit After Court Voids Canal Contracts
Hyundai Motor Group to Invest $6.26 Billion in AI Data Center, Robotics and Renewable Energy Projects in South Korea
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Santos Wins Court Case Over Net Zero and Sustainability Claims
Greg Abel’s First Berkshire Hathaway Shareholder Letter Signals Continuity, Caution, and Capital Discipline
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Flare, Xaman Roll Out One-Click DeFi Vault for XRP Yield via XRPL Wallets
BOJ Signals Possible April Rate Hike as Ueda Eyes Inflation and Wage Growth Data 



